New AI Model Improves Nuclei Segmentation in Histopathology Images
Researchers have developed AMN (Adaptive Multi-Scale Nuclei Network), a machine learning model that combines transformer and convolutional neural network approaches to better identify different types of cell nuclei in tissue samples. The model achieved a mean F1 score of 0.68 on a benchmark dataset with seven nuclei classes, outperforming eight existing baseline models. This advancement could improve accuracy in tumor grading, immune cell analysis, and disease prognosis prediction in pathology.
AMN is a dual-encoder segmentation framework that integrates a Swin Transformer and ResNet-50 feature pyramid through a learned gating mechanism that dynamically weights each encoder's contribution at multiple scales. The model uses a multi-objective loss function combining class-weighted focal loss, boundary-aware loss, and an uncertainty-modulated classification term designed to reduce overconfident incorrect predictions. Evaluated on the CoNIC benchmark across seven nuclei classes, AMN achieved a mean Dice coefficient of 0.82 and mean F1 of 0.68, with particularly strong performance on the diagnostically challenging lymphocyte class (F1 of 0.67). The model demonstrated superior performance compared to eight baseline architectures including U-Net, DeepLabV3+, ViT-Small, and several hybrid approaches. Cross-dataset validation on MoNuSeg showed strong generalization without retraining, indicating robust domain transfer capabilities.
What's missing
The study does not discuss computational requirements (inference time, memory usage) or practical deployment considerations for clinical settings. The paper does not address potential limitations in handling nuclei types outside the seven classes tested, or how performance might vary across different tissue types and staining protocols beyond the datasets evaluated.
What different sources said
- arXiv physicsCenter
Patient-Level Diagnosis of Acute Myeloid Leukemia via Deep Learning Analysis of Bone Marrow Smear
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.